Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
Little report regarding immunotherapy for oral cancer has been shown. Since Oral immune tolerance has been proposed, we focused on the effect of innate immune system-associated factors in ant-tumor effect in oral cancer. We initially generated Fucci-expressing oral cancer cell line to evaluate cell cycle. Using this cell line, we found that little individual immune-related factor altered cell cycle distribution in response to anticancer reagents. However, we also observed that multiple immune-related factors did affect the cell cycle distribution altered by the anticancer drugs, indicating that immune-related factors may alter the anticancer effect in oral cancer.
|